1
|
Shirkavand A, Boroujeni ZN, Aleyasin SA. Solanum nigrum Anticancer Effect Through Epigenetic Modulations in Breast Cancer Cell Lines. CCTR 2020. [DOI: 10.2174/1573394715666190101114541] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Background:
DNA methylation plays an important role in the regulation of gene expression
in mammalian cells and often occurs at CpG islands in the genome. It is more reversible
than genetic variations and has therefore attracted much attention for the treatment of many diseases,
especially cancer. In the present study, we investigated the effect of Solanum nigrum
Extract (SNE) on the methylation status of the VIM and CXCR4 genes in breast cancer cell lines.
Methods:
The Trypan blue assay was used to study the effect of SNE at various concentrations of
0, 0.1, 1.5, 2.5, 3.5 and 5 mg/ml for 48 h on the survival of three human breast cancer cell lines
MCF7, MDA-MB-468, MDA-MB-231. Methylation status of VIM and CXCR4 genes in breast
cancer cell lines was assessed by Methylation-Specific PCR (MSP) method. Also, methylation
changes of VIM and CXCR4 genes in breast cancer cell lines after treatment with 0.1 mg/ml of
SNE for 6 days were analyzed by MSP method. To confirm the effect of SNE on methylation of
VIM and CXCR4 genes, Real-Time PCR was performed.
Results:
The Trypan blue assay results indicated that treatment with SNE reduced cell viability in
a dose-dependent manner in breast cancer cells. Our results showed that treatment of breast cancer
cells with 0.1 mg/ml of SNE hypermethylated the VIM, CXCR4 genes and significantly reduced
the expression levels of their mRNA (P<0.05).
Conclusion:
Our findings reveal for the first time the impact of SNE on the methylation of breast
cancer cells.
Collapse
Affiliation(s)
- Atefeh Shirkavand
- Medical Biotechnology Division, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
| | - Zahra N. Boroujeni
- Medical Biotechnology Division, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
| | - Seyed A. Aleyasin
- Medical Biotechnology Division, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
| |
Collapse
|
2
|
Shirkavand A, Boroujeni ZN, Aleyasin SA. Examination of methylation changes of VIM, CXCR4, DOK7, and SPDEF genes in peripheral blood DNA in breast cancer patients. Indian J Cancer 2019; 55:366-371. [PMID: 30829272 DOI: 10.4103/ijc.ijc_100_18] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BACKGROUND Studying whole blood DNA methylation as a risk marker has valuable applications in either diagnosis or staging of breast cancer. We investigated whole blood DNA methylation status of VIM, CXCR4, DOK7, and SPDEF genes in breast cancer patients in comparison to healthy control subjects. MATERIALS AND METHODS 60 patients with breast cancer and 40 healthy controls were examined. Genomic DNA isolated from peripheral blood and restriction enzyme polymerase chain reaction (REP) method was applied for analysis. Real-time PCR was used to confirm methylation status of the aforementioned genes and therefore to find out the methylation differences between normal and breast cancer subjects. RESULTS Level of DOK7 promoter hypomethylation in normal and breast cancer samples was significant (P-value = 0.001). The study, also, showed that hypomethylation of VIM and CXCR4 genes are significant in patients compared with normal cases (P-value < 0.05). Furthermore, SPDEF promoter hypomethylation was not significantly differed between normal and breast cancer samples (P-value = 0.2). CONCLUSIONS Hypermethylation of DOK7 gene in DNA from patients affected with breast cancer offers a biomarker for diagnosis of the breast cancer. This study indicates that methylation status of VIM and CXCR4 genes changes in breast cancer; so, they can be used as molecular biomarkers in breast cancer prognosis.
Collapse
Affiliation(s)
- Atefeh Shirkavand
- Medical Biotechnology Division, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran
| | - Zahra Niki Boroujeni
- Medical Biotechnology Division, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran
| | - Seyed Ahmad Aleyasin
- Medical Biotechnology Division, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran
| |
Collapse
|
3
|
Zeinali S, Davoudi-Dehaghani E, Mahdieh N, Shirkavand A, Bagherian H, DabbaghBagheri S. SLC26A4 pathogenic variants as a third cause of hearing loss: Role of three exons in DFNB4 deafness in Iran. Indian J Otol 2019. [DOI: 10.4103/indianjotol.indianjotol_36_19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
4
|
Sadat-Larijani M, Derakhshani S, Keshavarz-Pakseresht B, Nasri-Nasrabadi A, Shirkavand A, Sadat-Shandiz SA, Baghbani-Arani F. Impact of a Missense Variation (p.S150R:AGC>AGG) in the XRCC2 Gene on Susceptibility to Colorectal Cancer. Clin Lab 2018; 64:233-237. [PMID: 29739106 DOI: 10.7754/clin.lab.2017.170717] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND The X-ray repair complementing defective repair in Chinese hamster cells 2 (XRCC2) is an important protein in response to DNA double-strand breaks (DSBs) in human cells. XRCC2, as a functional protein in the homologous recombination repair (HRR) process, has been identified to have several polymorphisms which might be associated with the risk of cancer. Therefore, we aimed to investigate a novel missense variation (AGC>AGG, p.Ser150Arg) in the XRCC2 gene for colorectal cancer susceptibility. METHODS We studied 291 colorectal cancer (CRC) patients and 140 healthy individuals. ARMS PCR method was used to detect the AGC>AGG (p.Ser150Arg) variation in the XRCC2 gene. RESULTS The results showed that there was a significant differential among CRC and controls in the genotypic and allelic frequencies (p < 0.001) of XRCC2; AGC>AGG, p.Ser150Arg. Our results demonstrated that the G allele of XRCC2; AGC>AGG, p.Ser150Arg was associated with increased CRC risk (odds ratio = 59.04, 95% confidence interval = 18.6 - 186). This variation also influenced CRC cancer susceptibility in smokers (p < 0.001). CONCLUSIONS The G allele of XRCC2; AGC>AGG, p.Ser150Arg, may be a potential marker for CRC in Iranians and investigations in other populations are warranted for further universal application in CRC detection and prediction.
Collapse
|
5
|
Bademci G, Foster J, Mahdieh N, Bonyadi M, Duman D, Cengiz FB, Menendez I, Diaz-Horta O, Shirkavand A, Zeinali S, Subasioglu A, Tokgoz-Yilmaz S, Huesca-Hernandez F, de la Luz Arenas-Sordo M, Dominguez-Aburto J, Hernandez-Zamora E, Montenegro P, Paredes R, Moreta G, Vinueza R, Villegas F, Mendoza-Benitez S, Guo S, Bozan N, Tos T, Incesulu A, Sennaroglu G, Blanton SH, Ozturkmen-Akay H, Yildirim-Baylan M, Tekin M. Comprehensive analysis via exome sequencing uncovers genetic etiology in autosomal recessive nonsyndromic deafness in a large multiethnic cohort. Genet Med 2015. [PMID: 26226137 PMCID: PMC4733433 DOI: 10.1038/gim.2015.89] [Citation(s) in RCA: 104] [Impact Index Per Article: 11.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
Purpose Autosomal recessive non-syndromic deafness (ARNSD) is characterized by a high degree of genetic heterogeneity with reported mutations in 58 different genes. This study was designed to detect deafness causing variants in a multiethnic cohort with ARNSD by using whole-exome sequencing (WES). Methods After excluding mutations in the most common gene, GJB2, we performed WES in 160 multiplex families with ARNSD from Turkey, Iran, Mexico, Ecuador and Puerto Rico to screen for mutations in all known ARNSD genes. Results We detected ARNSD-causing variants in 90 (56%) families, 54% of which had not been previously reported. Identified mutations were located in 31 known ARNSD genes. The most common genes with mutations were MYO15A (13%), MYO7A (11%), SLC26A4 (10%), TMPRSS3 (9%), TMC1 (8%), ILDR1 (6%) and CDH23 (4%). Nine mutations were detected in multiple families with shared haplotypes suggesting founder effects. Conclusion We report on a large multiethnic cohort with ARNSD in which comprehensive analysis of all known ARNSD genes identifies causative DNA variants in 56% of the families. In the remaining families, WES allows us to search for causative variants in novel genes, thus improving our ability to explain the underlying etiology in more families.
Collapse
Affiliation(s)
- Guney Bademci
- Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Joseph Foster
- Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Nejat Mahdieh
- Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
| | - Mortaza Bonyadi
- Faculty of Natural Sciences, Center of Excellence for Biodiversity, University of Tabriz, Tabriz, Iran
| | - Duygu Duman
- Division of Genetics, Department of Pediatrics, Ankara University School of Medicine, Ankara, Turkey
| | - F Basak Cengiz
- Division of Genetics, Department of Pediatrics, Ankara University School of Medicine, Ankara, Turkey
| | - Ibis Menendez
- Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Oscar Diaz-Horta
- Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, USA
| | | | - Sirous Zeinali
- Kawsar's Human Genetic Research Center, Tehran, Iran.,Department of Molecular Medicine, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
| | - Asli Subasioglu
- Department of Medical Genetics, Izmir Katip Celebi University, Ataturk Training and Research Hospital, Izmir, Turkey
| | - Suna Tokgoz-Yilmaz
- Department of Audiology, Hacettepe University Health Sciences Faculty, Ankara, Turkey
| | | | | | | | | | | | | | | | | | | | | | - Shengru Guo
- Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Nazim Bozan
- Department of Otolaryngology, Faculty of Medicine, Yuzuncu Yıl University, Van, Turkey
| | - Tulay Tos
- Department of Medical Genetics, Dr. Sami Ulus Research and Training Hospital of Women's and Children's Health and Diseases, Ankara, Turkey
| | - Armagan Incesulu
- Department of Otolaryngology, Head and Neck Surgery, Eskisehir Osmangazi University, Eskisehir, Turkey
| | - Gonca Sennaroglu
- Department of Audiology, Hacettepe University Health Sciences Faculty, Ankara, Turkey
| | - Susan H Blanton
- Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Hatice Ozturkmen-Akay
- Department of Radiology, Istanbul Zeynep Kamil Maternity and Children Training and Research Hospital, Istanbul, Turkey
| | | | - Mustafa Tekin
- Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, USA
| |
Collapse
|
6
|
Azarkeivan A, Hashemieh M, Akhlaghpoor S, Shirkavand A, Yaseri M, Sheibani K. Relation between serum ferritin and liver and heart MRI T2* in beta thalassaemia major patients. East Mediterr Health J 2013. [DOI: 10.26719/2013.19.8.727] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
7
|
Azarkeivan A, Hashemieh M, Akhlaghpoor S, Shirkavand A, Yaseri M, Sheibani K. Relation between serum ferritin and liver and heart MRI T2* in beta thalassaemia major patients. East Mediterr Health J 2013; 19:727-732. [PMID: 24975358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 09/15/2011] [Accepted: 06/03/2012] [Indexed: 06/03/2023]
Abstract
There is a need for higly accurate non-invasive methods for assessing organ iron content in thalassaemia patients. This study evaluated the relation between serum ferritin level, liver enzyme levels and hepatitis C antibody and liver and heart iron deposition assessed by MRI T2*. Data were obtained from the medical records of 156 thalassemia major patients in Tehran. There was a moderate negative correlation between serum ferritin and liver MRI T2* relaxation time (r = -0.535) and a weak negative correlation between serum ferritin and heart MRI T2* relaxation time (r = -0.361). Hepatitis C infection and liver enzyme levels did not confound or modify the relation between ferritin and liver or heart MRI T2*. Liver and heart MRI T2* readings were poorly correlated (r = 0.281). Routine evaluation of liver and heart iron content using MRI T2* is suggested to better evaluate the haemosiderosis status in thalassemia patients.
Collapse
|
8
|
Davoudi-Dehaghani E, Zeinali S, Mahdieh N, Shirkavand A, Bagherian H, Tabatabaiefar MA. A transversion mutation in non-coding exon 3 of the TMC1 gene in two ethnically related Iranian deaf families from different geographical regions; evidence for founder effect. Int J Pediatr Otorhinolaryngol 2013; 77:821-6. [PMID: 23523375 DOI: 10.1016/j.ijporl.2013.02.021] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/18/2012] [Revised: 02/23/2013] [Accepted: 02/25/2013] [Indexed: 11/18/2022]
Abstract
OBJECTIVES Transmembrane channel-like 1 (TMC1) gene is a member of the transmembrane channel-like (TMC) gene family that encodes an integral membrane protein of the inner ear. It is suggested that mutation in this gene is one of the main causes of autosomal recessive non-syndromic hearing loss (ARNSHL) in different populations. The aim of this study was to determine the contribution of the TMC1 gene mutations in causing hearing loss in Iran. METHODS In total 54 unrelated Iranian families containing 159 affected individuals with ARNSHL detected by audiometric and otologic examinations were analyzed. Haplotype analysis of all members of 45 GJB2- & GJB6-negative families, using four microsatellite markers linked to DFNB7/11 was performed. RESULTS Co-segregation of hearing loss with all investigated markers for the DFNB7/11 locus was found in one family. DNA sequencing of all coding and non-coding exons and intron boundaries of the TMC1 gene identified c.-258A>C mutation in non-coding exon 3 only in individuals with hearing loss. This mutation has been previously reported in another Iranian family (G9) that share similar ethnicity. This variant was not detected in 300 ethnically matched healthy controls. CONCLUSIONS These results increase the probability that this nucleotide variation may be a pathogenic mutation. This study showed that the ethnicity may be more useful than geographical location to design research strategy for determining which genes should be considered when a heterogeneous disorder is under investigation.
Collapse
Affiliation(s)
- Elham Davoudi-Dehaghani
- Department of Molecular Medicine, Biotechnology Research Center, Pasteur Institute of Iran, Pasteur St., Tehran, Iran
| | | | | | | | | | | |
Collapse
|
9
|
Mahdieh N, Shirkavand A, Rabbani B, Tekin M, Akbari B, Akbari MT, Zeinali S. Screening of OTOF mutations in Iran: a novel mutation and review. Int J Pediatr Otorhinolaryngol 2012; 76:1610-5. [PMID: 22906306 DOI: 10.1016/j.ijporl.2012.07.030] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/15/2012] [Revised: 07/21/2012] [Accepted: 07/27/2012] [Indexed: 10/28/2022]
Abstract
OBJECTIVE Mutations in OTOF have been reported to cause nonsyndromic hearing loss in different populations. The purpose of this study is screening of OTOF mutations in Iranian population. METHODS Thirty-eight consanguineous families affected with autosomal recessive nonsyndromic hearing loss (ARNSHL) and negative for GJB2 or GJB6 mutations were screened by autozygosity mapping and Sanger sequencing to find OTOF mutations. RESULTS A novel homozygous frameshift mutation (c.1981dupG) was found to cause hearing loss in one family and no other OTOF variants were detected in the remaining families. The affected individuals were homozygous forp. D661GfsX2 causing defect in long isoform of otoferlin. CONCLUSIONS We conclude that OTOF mutations are not the major cause of ARNSHL in the Iranian population but still may play an important role in HL; therefore evaluation the OTOF gene is of concern.
Collapse
Affiliation(s)
- Nejat Mahdieh
- Medical Genetic Group, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
| | | | | | | | | | | | | |
Collapse
|
10
|
Ghasemi A, Mahdieh N, Tavallaei M, Aslani MM, Zafari Z, Shirkavand A, Farzad MS, Naderi M, Azariyan SH, Zeinali S. Design of a biological method for rapid detection of presence of PCR inhibitors in aged bone DNA. Clin Lab 2012; 58:681-686. [PMID: 22997968] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
BACKGROUND Molecular human identification is one of the most important tests performed in forensic laboratories. Some of these tests are applied for identification of human remains from natural disasters, wars, etc., but problems may occur as a result of DNA degradation and external DNA contamination. We investigated effects of bacterial DNA on identifying the presence or absence of PCR inhibitors in aged bone DNA. METHODS DNA samples were extracted from blood, bone remains and Escherichia coli. These DNA were amplified using human and bacterial specific primers. RESULTS Using different blood, aged bone, and bacterial DNA dilutions along with PCR based methods; we checked their positive, negative effects, or detecting presence of inhibitors in aged bone DNA by PCR method. CONCLUSIONS Our observation indicated that the addition of bacterial DNA could be a valid biological method for testing the quality of bone DNA to enable us to obtain a usable profile for the identification of human remains. This method will help to test the presence of inhibitors, quantity or even quality of DNA which are of importance in profiling archeological remains. Our method will help to determine if PCR failure is due to presence of inhibitors or lack of amplifiable DNA either because of degradation, minute amount or absence of human DNA.
Collapse
Affiliation(s)
- Akram Ghasemi
- Human Genetics Research Center, Baqyatallah University of Medical Sciences, Tehran, Iran
| | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Mahdieh N, Rabbani B, Shirkavand A, Bagherian H, Movahed ZS, Fouladi P, Rahiminejad F, Masoudifard M, Akbari MT, Zeinali S. Impact of Consanguineous Marriages in GJB2-Related Hearing Loss in the Iranian Population: A Report of a Novel Variant. Genet Test Mol Biomarkers 2011; 15:489-93. [DOI: 10.1089/gtmb.2010.0145] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Nejat Mahdieh
- Kawsar Human Genetic Research Center, Tehran, Iran
- Medical Genetic Group, Ilam University of Medical Sciences, Ilam, Iran
- Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
| | - Bahareh Rabbani
- Growth and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran
- Medical Genetic Group, Ghazvin University of Medical Sciences, Ghazvin, Iran
| | | | | | | | | | | | | | - Mohammad Taghi Akbari
- Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
| | - Sirous Zeinali
- Kawsar Human Genetic Research Center, Tehran, Iran
- Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
| |
Collapse
|
12
|
Cuzzi J, Hughes M, Serafini P, Motta E, Hassun P, Karimi M, Shirkavand A, Omani Samani R, Singh R, Singh M, Maldonado LG, Setti AS, Franco Jr. JG, Braga DPAF, Figueira RCS, Iaconelli Jr. A, Borges Jr. E, Pourmatroud E, Hormozi L, Hemadi M. POSTER VIEWING SESSION - DEVELOPING COUNTRIES AND INFERTILITY. Hum Reprod 2011. [DOI: 10.1093/humrep/26.s1.77] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
13
|
Mahdieh N, Shirkavand A, Raeisi M, Akbari MT, Tekin M, Zeinali S. Unexpected heterogeneity due to recessive and de novo dominant mutations of GJB2 in an Iranian family with nonsyndromic hearing loss: Implication for genetic counseling. Biochem Biophys Res Commun 2010; 402:305-7. [DOI: 10.1016/j.bbrc.2010.10.021] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2010] [Accepted: 10/05/2010] [Indexed: 10/19/2022]
|
14
|
Mahdieh N, Bagherian H, Shirkavand A, Sharafi M, Zeinali S. High level of intrafamilial phenotypic variability of non-syndromic hearing loss in a Lur family due to delE120 mutation in GJB2 gene. Int J Pediatr Otorhinolaryngol 2010; 74:1089-91. [PMID: 20609484 DOI: 10.1016/j.ijporl.2010.06.005] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/28/2010] [Revised: 06/07/2010] [Accepted: 06/09/2010] [Indexed: 11/29/2022]
Abstract
Hearing loss is the most common sensory defect in the world. The genetic basis of this condition is very complex. Molecular variations in GJB2 gene are the common cause of hearing impairment in Caucasians. One expects that affected members of a family with same mutation have similar phenotype. Here, we report phenotypic variability in hearing loss among the members of a Lur family. Two brothers from a Lur family from Lurestan province in western Iran with variable degrees of nonsyndromic sensorineural hearing loss were evaluated for genetic counseling. Clinical examinations, audiological tests and molecular studies including GJB2 gene sequencing and detection of Delta(GJB6-D13S1830) deletion were performed. Sequencing analysis of GJB2 gene revealed delE120 mutation in both brothers in homozygous form. Since one of them was profoundly deaf and the other was mild hearing loss and had normal conversation, we were expecting different genotypes or other causative effects. Delta(GJB6-D13S1830) was not found. Phenotypic variability between members of different families with the same type of mutation can be expected which may be due to the role of different modifying factors, unrecognized gap junction isoforms, or polymorphism effects.
Collapse
Affiliation(s)
- Nejat Mahdieh
- Department of Medical Genetics, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran
| | | | | | | | | |
Collapse
|
15
|
Silva V, Pita Barros P, Lourenco O, Batel Marques F, Martinez-Salazar J, Palumbo A, De La Fuente P, Rodriguez M, Sanchez F, Lizan C, Marqueta J, Espallardo O, Lizan L, Polanco C, Paz S, Haagen EC, Nelen WLDM, Hermens RPMG, Adang EM, Grol RPTM, Kremer JAM, Pinborg A, Hougaard CO, Nyboe Andersen A, Kragh Andersen P, Boivin J, Schmidt L, Moolenaar L, Broekmans FB, van de Veen F, Fauser BCJM, Hompes P, Mol BW, Porcu - Buisson G, Lehert P, Chabert - Orsini V, Giorgetti C, Shirkavand A, Sedigh Sarvestani R, Ezabadi Z, Omani Samani R, Silva Carvalho JL, Santos A, Tabuas I, Braga DPAF, Setti AS, Figueira RCS, Queiroz P, Iaconelli A, Borges E, Fuldeore M, Wu N, Boulanger L, Chwalisz K, Marx S, Scaravelli G, De luca R, D'Aloja P, Vigiliano V, Mayorga JM, Bolli S, Spoletini R, Fiaccavento S, Monzo A, Flores R, Aniorte S, Rubio JM, Peinado I, Pellicer A, Woodward BJ, Sohan K, Dahl E, Ziegler A, Horlbeck S, Strowitzki T, Eggert-Kruse W, Padhy N, Mahla A, Balasubramanyam S, Varma TR, Yellamareddygari S, Willett MJ, Batra S, Farquhar C, Wang YA, Sullivan AE. Posters * Demography, Epidemiology, Registries, and Health Economy. Hum Reprod 2010. [DOI: 10.1093/humrep/de.25.s1.100] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
16
|
Mahdieh N, Raeisi M, Shirkavand A, Bagherian H, Akbari MT, Zeinali S. Investigation of GJB6 large deletions in Iranian patients using quantitative real-time PCR. Clin Lab 2010; 56:467-471. [PMID: 21086793] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
BACKGROUND Hearing loss is a serious sensory defect in the world. Mutations in the GJB2 and GJB6 genes are the major causes of autosomal recessive nonsyndromic hearing loss (NSHL). Recently, three major large deletions in the GJB6 gene including del(GJB6-D13S1830), del(GJB6-D13S1854), and a > 920 kb deletion have been reported to form double heterozygosity with GJB2. This may suggest that deletions involving GJB6 may be responsible for some NSHL. METHODS We designed a real time SYBR green-based PCR to quantify a common deleted region in GJB6 gene. The amplified region covers the area which has been seen to be deleted in all of the above reports. We selected nine families heterozygous for different mutations in GJB2 gene to investigate the presence of deletions in the GJB6 gene. The samples were run along with controls for normal hearing and heterozygous and homozygous for GJB2 mutations to optimize our method. As a reference gene or external standard, a segment of the CLCN7 gene was also quantified as well. RESULTS We did not detect any deletion in the GJB6 gene. CONCLUSIONS Using this method, any deletion involving GJB6 gene can be detected in a rapid and sensitive way.
Collapse
Affiliation(s)
- Nejat Mahdieh
- Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
| | | | | | | | | | | |
Collapse
|
17
|
Sarkar S, Hejazi M, Ataie-Fashtami L, Shirkavand A, Alinaghizadeh MR. Evaluation of litcit software for thermal simulation of hair removal lasers. Indian J Dermatol 2007. [DOI: 10.4103/0019-5154.35094] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
18
|
Hashemieh M, Javadzadeh M, Shirkavand A, Sheibani K. Lipid profile in minor thalassemic patients: a historical cohort study. ACTA ACUST UNITED AC 1970; 37:24-7. [DOI: 10.3329/bmrcb.v37i1.7795] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Minor beta thalassemia is a disorder without any special symptom which only causes mild anemia. In thalassemic patients accelerated erythropoiesis and enhanced cholesterol consumption have been suggested as the dominant mechanism for low level of lipoproteins. Hyperlipidemia is a risk factor for cardiovascular diseases and hence, low level of serum lipids can act as a protective factor. Because of the differences between social, economic, cultural conditions, dietary habits and genetics patterns among Iranians with other nations, this survey was conducted to verify these parameters among our thalassemia minor subjects. This study was carried out on 100 thalassemia carriers and 200 normal controls. Blood samples were collected and the biochemical evaluation was performed for measuring serum total cholesterol, LDL, HDL, TG, VLD. Descriptive statistical tables, independent t-test, Mann- Whitney and Chi-square were used for analyzing the data. The average values of serum total cholesterol, TG, LDL, HDL and VLDL in thalassemia minor subjects were 163.63±34.28, 159.74±157.54, 90.97±23.94, 34.97±8.07 and 73.44±72.43 mg/dl respectively. Moreover, the mean levels of total cholesterol, TG, LDL, HDL and VLDL in normal subjects were 192.77±37.27, 155.67±109.58, 123.42±33.57, 38.02±15.6 and 71.57±50.5 mg/dl respectively. The amount of serum total cholesterol and LDL in thalassemia carriers was significantly lower than normal subjects that shows the potential decline of cardiovascular and brain vessels diseases among thalassemia minor subjects compared to control group while other factors between the two groups did not show any significant difference. DOI: http://dx.doi.org/10.3329/bmrcb.v37i1.7795 Bangladesh Med Res Counc Bull 2011; 37: 24 - 27
Collapse
|